• Careers
  • News and Events
  • Investors
  • PAREXEL Japan
  •  
Locate a Pharmaceutical Consulting Partner
Pharmaceutical Development Library
PAREXEL Career Center
PAREXEL - Be an Investigator

ISPOR 15th Annual International Meeting

May 15, 2010 – May 19, 2010
Atlanta, GA - Hilton Atlanta

POSTER SESSION I
Monday, May 17, 8:00 AM - 8:30 PM
PMC39: Tapping Into a New Data Collection Paradigm: Using Direct To Patient Programs For More Cost Effective Study Management
Ramita Tandon, Senior Director, Operations, PACE

POSTER SESSION I
Monday, May 17, 8:00 AM - 8:30 PM
PMC16: Review of Cost Effectiveness Studies of High Budget Impact Drugs
Saurabh Aggarwal, Principal Consultant, Reimbursement & Market Access

POSTER SESSION I
Monday, May 17, 8:00 AM - 8:30 PM
PCN150: Trends in Usage and Uptake of Targeted Cancer Thereapies Versus Chemotherapies
Saurabh Aggarwal, Principal Consultant, Reimbursement & Market Access

POSTER SESSION I
Monday, May 17, 8:00 AM - 8:30 PM
PCN85: Economic Modeling For Treatment Failure Patients Using Multiple Rounds of Therapy as Comparator: Case In Point Lymphoma Drug Candidate
Saurabh Aggarwal, Principal Consultant, Reimbursement & Market Access

POSTER SESSION II
Tuesday, May 18, 8:00 AM - 8:00 PM
PMH64: Use Of Patient Support System To Increase Compliance for Opioid Addicted Patients
Saurabh Aggarwal, Principal Consultant, Reimbursement & Market Access

POSTER SESSION II
Tuesday, May 18, 8:00 AM - 8:00 PM
PHP3: Effectiveness of a Patient Persistency Program to Increase Compliance for Vaccination
Saurabh Aggarwal, Principal Consultant, Reimbursement & Market Access

Poster Session III
Wednesday, May 19, 8:00 am – 3:00 pm
PRS2: A Novel Methodology for Measuring the Influence of Comorbidity in Health Outcome Studies
Victor Kiri, Director, Pharmacoepidemiology

POSTER SESSION III
Wednesday, May 19, 8:00 AM - 3:00 PM
PRS48: Assessing the Time-Dependent Nature of Co-morbidity Influence in COPD
Victor Kiri, Director, Pharmacoepidemiology

POSTER SESSION III
Wednesday, May 19, 8:00 AM - 3:00 PM
PRS4: Estimation of Mortality Risks Attributable to Co-morbidity in COPD
Victor Kiri, Director, Pharmacoepidemiology

Event Website >

About PAREXEL

PAREXEL is a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.

PAREXEL Speakers Bureau

PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.

In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.